Furthermore, ABO blood group antigens have been shown to modulate the innate immune response to various pathogens through their glycan moieties [23] and variants in the ABO gene group locus have been shown in a large European study to correlate with the development of respiratory failure in patients with COVID-19 [14]. This evidence concerns the gene ABO and COVID-19.